These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2859044)

  • 1. Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales.
    Lewis RV; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1985 Feb; 19(2):255-7. PubMed ID: 2859044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-effects of beta-blockers assessed using visual analogue scales.
    Lewis RV; Jackson PR; Ramsay LE
    Eur J Clin Pharmacol; 1985; 28 Suppl():93-6. PubMed ID: 2865155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring side-effects of beta-adrenoceptor antagonists: a comparison of two methods.
    Lewis RV; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1985 Jun; 19(6):826-8. PubMed ID: 2862895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of side-effects of beta-adrenoceptor blockers using visual analogue scales.
    Lewis RV; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1984 Sep; 18(3):325-30. PubMed ID: 6148958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 7. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
    Nederfors T
    Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Raynaud's phenomenon as side effect of beta-blockers.
    Marshall A; Barritt DW; Roberts CJ
    Br Med J; 1976 Jul; 2(6030):301. PubMed ID: 8186
    [No Abstract]   [Full Text] [Related]  

  • 9. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
    Adam WR; Meagher EJ; Barter CE
    Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs.
    Brismar K; Mogensen L; Wetterberg L
    Acta Med Scand; 1987; 221(2):155-8. PubMed ID: 2884812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.
    Dimenäs E; Dahlöf C; Olofsson B; Wiklund I
    Br J Clin Pharmacol; 1989 Nov; 28(5):527-34. PubMed ID: 2574052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor blockers and the blood-brian barrier.
    Neil-Dwyer G; Bartlett J; McAinsh J; Cruickshank JM
    Br J Clin Pharmacol; 1981 Jun; 11(6):549-53. PubMed ID: 6115665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
    Dal Negro RW; Zoccatelli O; Pomari C; Trevisan F; Turco P
    Int J Clin Pharmacol Res; 1986; 6(4):283-9. PubMed ID: 2875954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.